About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Igfbp7tm1.1Dds
targeted mutation 1.1, Demetri D Spyropoulos
MGI:5618913
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Igfbp7tm1.1Dds/Igfbp7tm1.1Dds involves: CD-1 MGI:5660900
ht2
Igfbp7tm1.1Dds/Igfbp7+ involves: CD-1 MGI:5661468


Genotype
MGI:5660900
hm1
Allelic
Composition
Igfbp7tm1.1Dds/Igfbp7tm1.1Dds
Genetic
Background
involves: CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igfbp7tm1.1Dds mutation (0 available); any Igfbp7 mutation (20 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• on days 9 and 16 of pregnancy, mutant glands show reduced gland size and weight and are less dense than wild-type
• mutant alveolar units are very small and display a disrupted architecture
• homozygotes show a 40% decrease in litter size at first pregnancy
• litter size continues to decline in multiparous females

endocrine/exocrine glands
• on pregnancy day 16 and lactation day 3, mutant glands display a decreased proliferation index, with significantly fewer Ki-67 positive cells than wild-type glands
• virgin and adult homozygotes display retarded mammary gland development relative to wild-type controls
• mutant glands are smaller and less dense at 3-week or 11-week old, pregnant and lactating homozygotes
• at 11 weeks of age, virgin mutant glands display much less elaborated alveolar structures and a 3-fold reduction in ductal tips, suggesting decreased branching morphogenesis
• however, mammary gland weight is normal at 11 weeks
• on lactation day 3, mutant alveolar structures resemble those seen in wild-type glands at 3 weeks postpartum, with alveolar sacs appearing to be undergoing early stages of involution
• transcriptome profiling of mutant lactating glands revealed an involution-related gene signature relative to wild-type glands
• lactating mutant glands exhibit decreased Stat5 and AKT signaling along with increased Stat3 signaling, suggesting precocious involution of the mammary gland through reduced cell survival signals
• on lactation days 1 and 3, mutant glands show reduced gland size and weight and are less dense than wild-type
• mutant alveolar units are very small and display a disrupted architecture
• on lactation day 3, mutant alveolar structures resemble those seen in wild-type glands at 3 weeks postpartum
• on days 9 and 16 of pregnancy, mutant glands show reduced gland size and weight and are less dense than wild-type
• mutant alveolar units are very small and display a disrupted architecture
• at 3 weeks, virgin homozygotes display a ~3-fold reduction in the number of terminal end buds (TEBs) relative to wild-type controls
• alveolar development is completely defective during pregnancy and lactation, with smaller and partially closed alveolar sacs
• at 3 weeks postpartum, mutant glands appear highly malformed, disorganized, and contain fewer alveolar structures
• in matrigel culture, mutant mammary epithelial cells (MECs) form smaller unorganized alveolar structures that fail to differentiate into multi-lobular structures in the presence of prolactin, unlike wild-type MECs; however, addition of recombinant IGFBP7 is sufficient to restore the alveolar differentiation defect
• although mutant glands are capable of producing milk during lactation days 1 and 3, they appear to have less beta-casein staining on day 3 than wild-type controls
• on lactation day 1, cytoplasmic lipid droplets are observed, unlike in wild-type glands
• however, female homozygotes are fertile and capable of nursing their pups

integument
• on pregnancy day 16 and lactation day 3, mutant glands display a decreased proliferation index, with significantly fewer Ki-67 positive cells than wild-type glands
• virgin and adult homozygotes display retarded mammary gland development relative to wild-type controls
• mutant glands are smaller and less dense at 3-week or 11-week old, pregnant and lactating homozygotes
• at 11 weeks of age, virgin mutant glands display much less elaborated alveolar structures and a 3-fold reduction in ductal tips, suggesting decreased branching morphogenesis
• however, mammary gland weight is normal at 11 weeks
• on lactation day 3, mutant alveolar structures resemble those seen in wild-type glands at 3 weeks postpartum, with alveolar sacs appearing to be undergoing early stages of involution
• transcriptome profiling of mutant lactating glands revealed an involution-related gene signature relative to wild-type glands
• lactating mutant glands exhibit decreased Stat5 and AKT signaling along with increased Stat3 signaling, suggesting precocious involution of the mammary gland through reduced cell survival signals
• on lactation days 1 and 3, mutant glands show reduced gland size and weight and are less dense than wild-type
• mutant alveolar units are very small and display a disrupted architecture
• on lactation day 3, mutant alveolar structures resemble those seen in wild-type glands at 3 weeks postpartum
• on days 9 and 16 of pregnancy, mutant glands show reduced gland size and weight and are less dense than wild-type
• mutant alveolar units are very small and display a disrupted architecture
• at 3 weeks, virgin homozygotes display a ~3-fold reduction in the number of terminal end buds (TEBs) relative to wild-type controls
• alveolar development is completely defective during pregnancy and lactation, with smaller and partially closed alveolar sacs
• at 3 weeks postpartum, mutant glands appear highly malformed, disorganized, and contain fewer alveolar structures
• in matrigel culture, mutant mammary epithelial cells (MECs) form smaller unorganized alveolar structures that fail to differentiate into multi-lobular structures in the presence of prolactin, unlike wild-type MECs; however, addition of recombinant IGFBP7 is sufficient to restore the alveolar differentiation defect
• although mutant glands are capable of producing milk during lactation days 1 and 3, they appear to have less beta-casein staining on day 3 than wild-type controls
• on lactation day 1, cytoplasmic lipid droplets are observed, unlike in wild-type glands
• however, female homozygotes are fertile and capable of nursing their pups

growth/size/body
• surviving mutant pups show a persistent decrease in body weight through postpartum day 12, consistent with reduced beta-casein expression in the lactating glands

cellular
• in culture, mutant mouse embryonic fibroblasts (MEFs) show decreased proliferation potential relative to wild-type MEFs
• on pregnancy day 16 and lactation day 3, mutant glands display a decreased proliferation index, with significantly fewer Ki-67 positive cells than wild-type glands




Genotype
MGI:5661468
ht2
Allelic
Composition
Igfbp7tm1.1Dds/Igfbp7+
Genetic
Background
involves: CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igfbp7tm1.1Dds mutation (0 available); any Igfbp7 mutation (20 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• at 11 weeks of age, virgin heterozygotes display a significant reduction in mammary ductal tips, although to a lesser extent than that observed in homozygotes
• at 3 weeks, virgin heterogotes display a significantly decreased number of terminal end buds (TEBs), comparable to that observed in homozygotes

integument
• at 11 weeks of age, virgin heterozygotes display a significant reduction in mammary ductal tips, although to a lesser extent than that observed in homozygotes
• at 3 weeks, virgin heterogotes display a significantly decreased number of terminal end buds (TEBs), comparable to that observed in homozygotes





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory